(Q31561882)

English

Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

0 references

Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

O'Shea E

1

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Esteban B

2

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Camarero J

3

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Green AR

4

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Colado MI

5

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

65-74

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: Specific inhibitors of dopamine uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy).

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

MDMA induced dopamine release in vivo: role of endogenous serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Neurotoxicity of MDMA and related compounds: anatomic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Neurotoxicity of MDMA: neurochemical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine ("Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Intrasynaptosomal sequestration of [3H]amphetamine and [3H]methylenedioxyamphetamine: characterization suggests the presence of a factor responsible for maintaining sequestration.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900106-4

7 January 2021

Identifiers

10.1016/S0028-3908(00)00106-4

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31561882&oldid=1613068768"